LambdaVision
PrivateLast Round
Seed
Nov 5, 2025
Total Funding Raised
$12.75M
Momentum Score
25 /100
Company Overview
LambdaVision is a biotechnology company developing a protein-based artificial retina to restore meaningful vision for patients blinded by retinal degenerative diseases like retinitis pigmentosa and age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Space Technology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LambdaVision Comps
Public and private peers based on sector, stage, and business model.
LambdaVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 5, 2025 | ||||
| Grant | Jun 1, 2020 | ||||
| Grant | Apr 10, 2020 |
LambdaVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NASA | Grant |
| Seven Seven Six | Seed |
| Aurelia Foundry Fund | Seed |
| Seraphim Space | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Developing a protein-based artificial retina using space for development.
LambdaVision Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LambdaVision's valuation, stock price, and market status.
